Unique ID issued by UMIN | UMIN000000598 |
---|---|
Receipt number | R000000725 |
Scientific Title | Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial |
Date of disclosure of the study information | 2007/02/07 |
Last modified on | 2011/02/26 06:55:31 |
Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial
Adjuvant Chemotherapy With Gemcitabine in Biliary Cancer
Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial
Adjuvant Chemotherapy With Gemcitabine in Biliary Cancer
Japan |
Biliary Cancer
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery |
Malignancy
NO
To determine the safety and efficacy of a postoperative regimen with gemcitabine in patients undergoing curative-intent resection of biliary cancer
Efficacy
Confirmatory
Pragmatic
Phase I,II
Phase I: Safety
Phase II: Feasibility
Phase II: Safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Adjuvant chemotherapy with 6 cycles of gemcitabine on days 1, 8, and 15 every 4 weeks
20 | years-old | <= |
75 | years-old | > |
Male and Female
Patients with histologically verified biliary cancer who had macroscopic complete resection (>=stage II) and no prior radiation or chemotherapy
ECOG Performance Status 0-1
Adequate organ function (leukocytes>=4.0 X 109/L, neutrophils>=2.0 X 109/L, platelets>=100 X 109/L, hemoglobin>=9 g/dl, total bilirubin<=2 X upper limit of normal (ULN), AST, ALT<=4 X ULN, serum creatine<=ULN
No fever with infection
Adverse events other than blood/bone marrow<=grade 2 according to National Cancer Institute - Common Terminology Criteria for Adverse Events v3.0
Written informed consent
No major postoperative complication
Tolerable to chemotherapy within 12 weeks after surgery
Pulmonary fibrosis or interstitial pneumonia with radiological or clinical findings
Uncontrollable pleural effusion
Uncontrollable diabetes mellitus or liver dysfunction
With distant metastasis except lymph node metastasis
With uncured other malignancies
Active infection
Severe major postoperative complication such as peritonitis and massive bleeding
With active peptic ulcer
A history of myocardial infarction within 3 months
Psychiatric disorder
Pregnant or breast-feeding women, Women wishing for baby
26
1st name | |
Middle name | |
Last name | Etsuro Hatano |
Graduate School of Medicine
Kyoto University
Department of Surgery
54 Kawaharacho Shogoin Sakyoku Kyoto
075-751-3234
1st name | |
Middle name | |
Last name | Etsuro Hatano |
Graduate School of Medicine
Department of Surgery
54 Kawaharacho Shogoin Sakyoku Kyoto
075-751-3234
etsu@kuhp.kyoto-u.ac.jp
Department of Surgery
Graduate School of Medicine
Kyoto University
Department of Surgery
Graduate School of Medicine
Kyoto University
NO
2007 | Year | 02 | Month | 07 | Day |
Unpublished
Completed
2007 | Year | 01 | Month | 27 | Day |
2007 | Year | 02 | Month | 01 | Day |
2011 | Year | 01 | Month | 01 | Day |
2011 | Year | 01 | Month | 01 | Day |
2011 | Year | 01 | Month | 01 | Day |
2011 | Year | 01 | Month | 01 | Day |
2007 | Year | 02 | Month | 07 | Day |
2011 | Year | 02 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000725
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |